Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12128043 Pharmaceutical capsules comprising lumateperone mono-tosylate

Patent 12128043 was granted and assigned to Intra-Cellular Therapies on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Intra-Cellular Therapies
Intra-Cellular Therapies
0
Date Filed
March 12, 2024
0
Date of Patent
October 29, 2024
0
Patent Applicant
Intra-Cellular Therapies
Intra-Cellular Therapies
0
Patent Application Number
18602981
0
Patent Citations
‌
US Patent 7026498 Ligands for metals and improved metal-catalyzed processes based thereon
0
‌
US Patent 7071186 Substituted heterocycle fused gamma-carbolines
0
‌
US Patent 7081455 Substituted heterocycle fused gamma-carbolines
0
‌
US Patent 7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
0
‌
US Patent 7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
0
‌
US Patent 7183282 Substituted heterocycle fused γ-carbolines
0
‌
US Patent 7223879 Ligands for metals and improved metal-catalyzed processes based thereon
0
‌
US Patent RE39680 Substituted heterocycle fused gamma-carbolines
0
‌
US Patent 7238690 Substituted heterocycle fused gamma-carbolines
0
‌
US Patent 7247731 Ligands for metals and improved metal-catalyzed processes based thereon
0
•••
Patent Inventor Names
Peng Li
0
Robert Davis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12128043
0
Patent Primary Examiner
‌
Mark V Stevens
0
CPC Code
‌
A61K 31/4985
0
‌
A61K 9/48
0

Find more entities like US Patent 12128043 Pharmaceutical capsules comprising lumateperone mono-tosylate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo